Mo2075 Triptolide Demonstrates Novel Chemotherapeutic Potential as Single-Agent or Combination Therapy With Sorafenib for Treatment of Hepatocellular Carcinoma

Journal article

Peer reviewed

Tara C Krosch, Veena Sangwan, Sulagna Banerjee, Ashok Saluja, Eric H Jensen and Selwyn M Vickers

Gastroenterology (New York, N.Y. 1943), Vol.142(5), pp.S-1088-S-1088

2012-05

Metrics

7 Record Views

Title: Mo2075 Triptolide Demonstrates Novel Chemotherapeutic Potential as Single-Agent or Combination Therapy With Sorafenib for Treatment of Hepatocellular Carcinoma
Creators: Tara C Krosch
Veena Sangwan
Sulagna Banerjee
Ashok Saluja
Eric H Jensen
Selwyn M Vickers
Publication Details: Gastroenterology (New York, N.Y. 1943), Vol.142(5), pp.S-1088-S-1088
Academic Unit: Miller School of Medicine; UMMG Department of Surgery; UMMG Dept of Surgery - Div of Surgical Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031600495702976